Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
Merck
Johnson and Johnson
QuintilesIMS
Healthtrust
Boehringer Ingelheim
Dow
US Department of Justice

Generated: June 25, 2018

DrugPatentWatch Database Preview

Amphastar Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for AMPHASTAR PHARMS INC, and what generic and branded alternatives to AMPHASTAR PHARMS INC drugs are available?

AMPHASTAR PHARMS INC has six approved drugs.



Summary for Amphastar Pharms Inc
US Patents:0
Tradenames:5
Ingredients:5
NDAs:6

Drugs and US Patents for Amphastar Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharms Inc NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 209933-002 Sep 25, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Amphastar Pharms Inc DUOCAINE bupivacaine hydrochloride; lidocaine hydrochloride INJECTABLE;INJECTION 021496-001 May 23, 2003 DISCN No No ➤ Sign Up ➤ Sign Up
Amphastar Pharms Inc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209832-001 Dec 18, 2017 AP RX No No ➤ Sign Up ➤ Sign Up
Amphastar Pharms Inc MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 077235-001 Nov 28, 2017 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Express Scripts
Colorcon
Julphar
Teva
US Army
AstraZeneca
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.